Literature DB >> 32773954

The Role of Interventional Radiologists in the Treatment of Congenital Lymphatic Malformations.

Julie Cronan1, Anne E Gill1,2, Jay H Shah1,2, C Matthew Hawkins1,2.   

Abstract

Lymphatic malformations are low-flow vascular malformations that are typically apparent in the pediatric population and can cause significant functional limitations and effects on quality of life. While surgical resection has historically been the mainstay of therapy, percutaneous sclerotherapy has garnered increasing popularity due to its efficacy and low complication rates. The role of interventional radiology in the multidisciplinary management of these often complex malformations requires thorough understanding of the disease process. This article will review the pathophysiology, clinical presentation, imaging workup, and management options of lymphatic malformations. Special attention will be devoted to available sclerosants, the mammalian target of rapamycin inhibitor sirolimus, and complex lymphatic anomalies. © Thieme Medical Publishers.

Entities:  

Keywords:  lymphatic malformation; sclerotherapy; sirolimus

Year:  2020        PMID: 32773954      PMCID: PMC7394567          DOI: 10.1055/s-0040-1713446

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  78 in total

1.  25 years' experience with lymphangiomas in children.

Authors:  A Alqahtani; L T Nguyen; H Flageole; K Shaw; J M Laberge
Journal:  J Pediatr Surg       Date:  1999-07       Impact factor: 2.545

2.  Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly.

Authors:  Stacy E Croteau; Harry P W Kozakewich; Antonio R Perez-Atayde; Steven J Fishman; Ahmad I Alomari; Gulraiz Chaudry; John B Mulliken; Cameron C Trenor
Journal:  J Pediatr       Date:  2013-11-16       Impact factor: 4.406

3.  Angiopoietins as serum biomarkers for lymphatic anomalies.

Authors:  Timothy D Le Cras; Paula S Mobberley-Schuman; Mary Broering; Lin Fei; Cameron C Trenor; Denise M Adams
Journal:  Angiogenesis       Date:  2016-12-18       Impact factor: 9.596

Review 4.  Lymphatic malformations: review of current treatment.

Authors:  Jonathan A Perkins; Scott C Manning; Richard M Tempero; Michael J Cunningham; Joseph L Edmonds; Fredric A Hoffer; Mark A Egbert
Journal:  Otolaryngol Head Neck Surg       Date:  2010-06       Impact factor: 3.497

5.  Cryoablation of low-flow vascular malformations.

Authors:  Raja S Ramaswamy; Tatulya Tiwari; Michael D Darcy; Seung K Kim; Olaguoke Akinwande; Niloy Dasgupta; Carlos J Guevara
Journal:  Diagn Interv Radiol       Date:  2019-05       Impact factor: 2.630

Review 6.  Lasers for cutaneous congenital vascular lesions: a comprehensive overview and update.

Authors:  Katlein França; Anna Chacon; Jennifer Ledon; Jessica Savas; Jan Izakovic; Keyvan Nouri
Journal:  Lasers Med Sci       Date:  2012-10-24       Impact factor: 3.161

7.  Acute pulmonary toxicity following intralesional administration of bleomycin for a lymphovenous malformation.

Authors:  Khalid Atwa; Said Abuhasna; Zuhair Shihab; Nidal Hashaykeh; Rashed Hasan
Journal:  Pediatr Pulmonol       Date:  2010-02

8.  Use of percutaneous bleomycin sclerotherapy for orbital lymphatic malformations.

Authors:  Adam M Hanif; Justin A Saunders; C Matthew Hawkins; Ted H Wojno; Hee Joon Kim
Journal:  Orbit       Date:  2018-06-14

Review 9.  Lymphatic malformations: diagnosis and management.

Authors:  Ravindhra G Elluru; Karthik Balakrishnan; Horacio M Padua
Journal:  Semin Pediatr Surg       Date:  2014-07-15       Impact factor: 2.754

Review 10.  Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature.

Authors:  Michelle T Poldervaart; Corstiaan C Breugem; Lucienne Speleman; Suzanne Pasmans
Journal:  J Craniofac Surg       Date:  2009-07       Impact factor: 1.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.